Chapter/Section Purchase

1 Study Coverage
1.1 Therapeutic Radioisotopes Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Radioisotopes Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Radioisotopes Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Radioisotopes Sales by Region
2.4.1 Global Therapeutic Radioisotopes Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic Radioisotopes by Region (2023-2028)
2.5 Global Therapeutic Radioisotopes Revenue by Region
2.5.1 Global Therapeutic Radioisotopes Revenue by Region (2017-2022)
2.5.2 Global Therapeutic Radioisotopes Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic Radioisotopes Sales by Manufacturers
3.1.1 Global Top Therapeutic Radioisotopes Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radioisotopes in 2021
3.2 Global Therapeutic Radioisotopes Revenue by Manufacturers
3.2.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2021
3.3 Global Therapeutic Radioisotopes Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic Radioisotopes Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic Radioisotopes Sales by Type
4.1.1 Global Therapeutic Radioisotopes Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Radioisotopes Revenue by Type
4.2.1 Global Therapeutic Radioisotopes Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Radioisotopes Price by Type
4.3.1 Global Therapeutic Radioisotopes Price by Type (2017-2022)
4.3.2 Global Therapeutic Radioisotopes Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic Radioisotopes Sales by Application
5.1.1 Global Therapeutic Radioisotopes Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Radioisotopes Revenue by Application
5.2.1 Global Therapeutic Radioisotopes Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Radioisotopes Price by Application
5.3.1 Global Therapeutic Radioisotopes Price by Application (2017-2022)
5.3.2 Global Therapeutic Radioisotopes Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic Radioisotopes Market Size by Type
6.1.1 North America Therapeutic Radioisotopes Sales by Type (2017-2028)
6.1.2 North America Therapeutic Radioisotopes Revenue by Type (2017-2028)
6.2 North America Therapeutic Radioisotopes Market Size by Application
6.2.1 North America Therapeutic Radioisotopes Sales by Application (2017-2028)
6.2.2 North America Therapeutic Radioisotopes Revenue by Application (2017-2028)
6.3 North America Therapeutic Radioisotopes Market Size by Country
6.3.1 North America Therapeutic Radioisotopes Sales by Country (2017-2028)
6.3.2 North America Therapeutic Radioisotopes Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic Radioisotopes Market Size by Type
7.1.1 Europe Therapeutic Radioisotopes Sales by Type (2017-2028)
7.1.2 Europe Therapeutic Radioisotopes Revenue by Type (2017-2028)
7.2 Europe Therapeutic Radioisotopes Market Size by Application
7.2.1 Europe Therapeutic Radioisotopes Sales by Application (2017-2028)
7.2.2 Europe Therapeutic Radioisotopes Revenue by Application (2017-2028)
7.3 Europe Therapeutic Radioisotopes Market Size by Country
7.3.1 Europe Therapeutic Radioisotopes Sales by Country (2017-2028)
7.3.2 Europe Therapeutic Radioisotopes Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Radioisotopes Market Size by Type
8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Radioisotopes Market Size by Application
8.2.1 Asia Pacific Therapeutic Radioisotopes Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic Radioisotopes Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Radioisotopes Market Size by Region
8.3.1 Asia Pacific Therapeutic Radioisotopes Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Therapeutic Radioisotopes Market Size by Type
9.1.1 Latin America Therapeutic Radioisotopes Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic Radioisotopes Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Radioisotopes Market Size by Application
9.2.1 Latin America Therapeutic Radioisotopes Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic Radioisotopes Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Radioisotopes Market Size by Country
9.3.1 Latin America Therapeutic Radioisotopes Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic Radioisotopes Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Type
10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Radioisotopes Market Size by Application
10.2.1 Middle East and Africa Therapeutic Radioisotopes Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Radioisotopes Market Size by Country
10.3.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Overview
11.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 China Isotope & Radiation Recent Developments
11.4 Dongcheng
11.4.1 Dongcheng Corporation Information
11.4.2 Dongcheng Overview
11.4.3 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dongcheng Recent Developments
11.5 Q BioMed
11.5.1 Q BioMed Corporation Information
11.5.2 Q BioMed Overview
11.5.3 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Q BioMed Recent Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Corporation Information
11.6.2 Curium Pharmaceuticals Overview
11.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Curium Pharmaceuticals Recent Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Corporation Information
11.7.2 Jubilant DraxImage Overview
11.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jubilant DraxImage Recent Developments
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Overview
11.8.3 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Recent Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Corporation Information
11.9.2 Spectrum Pharmaceuticals Overview
11.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Spectrum Pharmaceuticals Recent Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Overview
11.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Progenics Pharmaceuticals Recent Developments
11.11 International Isotopes
11.11.1 International Isotopes Corporation Information
11.11.2 International Isotopes Overview
11.11.3 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic Radioisotopes Industry Chain Analysis
12.2 Therapeutic Radioisotopes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Radioisotopes Production Mode & Process
12.4 Therapeutic Radioisotopes Sales and Marketing
12.4.1 Therapeutic Radioisotopes Sales Channels
12.4.2 Therapeutic Radioisotopes Distributors
12.5 Therapeutic Radioisotopes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic Radioisotopes Industry Trends
13.2 Therapeutic Radioisotopes Market Drivers
13.3 Therapeutic Radioisotopes Market Challenges
13.4 Therapeutic Radioisotopes Market Restraints
14 Key Findings in The Global Therapeutic Radioisotopes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer